δ13 C values of urinary 19-norandrosterone in antidoping samples and potential for adverse findings from boar offal consumption
- PMID: 36929692
- DOI: 10.1002/dta.3470
δ13 C values of urinary 19-norandrosterone in antidoping samples and potential for adverse findings from boar offal consumption
Abstract
19-Norandrosterone (19NA) is the preferred urinary target compound to identify doping with nandrolone or related 19-norsteroids. At concentrations between 2.5 and 15 ng/mL, isotope ratio mass spectrometry (IRMS) is required to establish exogenous origin of urinary 19NA. An absolute difference of 3‰ between urinary 19NA and an endogenous reference compound (ERC) constitutes a finding for exogenous origin of 19NA. Over the last 3 years, 77 samples containing urinary 19NA between 2.5 and 15 ng/mL were analyzed at our laboratory. The measured δ13 C values for 19NA ranged from -29.5‰ to -16.8‰. In comparison, the δ13 C values for the corresponding urinary ERCs ranged from -22.4‰ to -16.2‰. Due to the considerable overlap in values between the target compound and the natural range of urinary ERCs, it can be challenging to distinguish between endogenous and exogenous origins of urinary 19NA. In addition, it is well known that consumption of offal from non-castrated pigs can produce 19NA in urine. To determine whether this could cause a positive IRMS finding under the current IRMS positivity criteria, meat from non-castrated boars fed a mixture of corn and soy was consumed by 13 volunteers. Two volunteers produced 19NA findings above 2.5 ng/mL, and the measured isotope values, while inconsistent with documented 19-norsteroid preparations, did meet IRMS positivity criteria. However, these increases in 19NA urinary concentrations were short-lived due to rapid elimination. Timely follow-up collections may help support a claim for dietary exposure when low urinary concentrations of 19NA with pseudo-endogenous isotope values are observed.
Keywords: 19-norandrosterone; carbon isotope ratio; offal.
© 2023 John Wiley & Sons Ltd.
References
REFERENCES
-
- WADA Technical Document - TD2021NA. Harmonization of analysis and reporting of 19-norsteroids related to nandrolone. Vol. 2021 (2021).
-
- Schänzer W. Metabolism of nortestosterone, norandrostenedione and norandrostenediol: identification of 3-hydroxyestr-4-en-17one glucuronide and 3a, 16a-dihydroxy-5a-estran-17-one glucuronide and sulphate. (ed. (8), P.o.t.t.C.W.o.D.N.R.A.i.D.A. Cologne: Sport und Buch Strauss; 2000:155-174.
-
- Reznik Y, Herrou M, Dehennin L, Lemaire M, Leymarie P. Rising plasma levels of 19-nortestosterone throughout pregnancy: determination by radioimmunoassay and validation by gas chromatography-mass spectrometry. J Clin Endocrinol Metab. 1987;64(5):1086-1088. doi:10.1210/jcem-64-5-1086
-
- Walker CJ, Cowan DA, James VH, Lau JC, Kicman AT. Doping in sport-1. Excretion of 19-norandrosterone by healthy women, including those using contraceptives containing norethisterone. Steroids. 2009;74(3):329-334. doi:10.1016/j.steroids.2008.10.008
-
- Ayotte C. Significance of 19-norandrosterone in athletes' urine samples. Br J Sports Med. 2006;40(Suppl 1):i25-i29. doi:10.1136/bjsm.2006.028027
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources